West Pharmaceutical Services (WST) Other Non Operating Income (2012 - 2026)

West Pharmaceutical Services has disclosed Other Non Operating Income across 12 years of filings, most recently posting -$200000.0 for Q1 2026.

• Other Non Operating Income for Q1 2026 came in at -$200000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.0 million (up 16.67% YoY), and the FY2025 annual result was -$1.0 million, changed 0.0% from the prior year.
• Other Non Operating Income came in at -$200000.0 for Q1 2026 at West Pharmaceutical Services, up from -$400000.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $3.8 million in Q3 2023 to a low of -$49.3 million in Q3 2022.
• The 5-year median for Other Non Operating Income is -$200000.0 (2025), against an average of -$3.9 million.
• Across the five-year window, Other Non Operating Income slumped 4581.82% in 2022 and jumped 107.71% in 2023, its largest moves.
• West Pharmaceutical Services' Other Non Operating Income stood at -$2.2 million in 2022, then soared by 59.09% to -$900000.0 in 2023, then jumped by 66.67% to -$300000.0 in 2024, then plunged by 33.33% to -$400000.0 in 2025, then surged by 50.0% to -$200000.0 in 2026.
• The last three Other Non Operating Income figures came in at -$200000.0 (Q1 2026), -$400000.0 (Q4 2025), and -$200000.0 (Q3 2025), per Business Quant data.